Rapid spectrophotometric technique for quantifying iron in cells labeled with superparamagnetic iron oxide nanoparticles: Potential translation to the clinic

Contrast Media and Molecular Imaging

Volumn 8, Issue 1, 2013, Pages 50-56

  Dadashzadeh, Esmaeel R ^a   Hobson, Matthew ^a   Henry Bryant, L ^a   Dean, Dana D ^a   Frank, Joseph A ^a,b  

^a NATIONAL INSTITUTES OF HEALTH   (United States)

^b NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING   (United States)

Author keywords

Cell labeling; Ferumoxides; Ferumoxytol; ICP MS; Iron content; MRI; Prussian Blue; Relaxometry; Spectrophotometry; Stem cells; Superparamagnetic iron oxide nanoparticles

Indexed keywords

DODECYL SULFATE SODIUM; IRON; SUPERPARAMAGNETIC IRON OXIDE NANOPARTICLE;

ABSORPTION; ARTICLE; ATOMIC EMISSION SPECTROMETRY; CELL LABELING; CHEMICAL REACTION; HUMAN; HUMAN CELL; LIMIT OF DETECTION; NUCLEAR MAGNETIC RESONANCE; PRIORITY JOURNAL; TURBIDITY; ULTRAVIOLET SPECTROSCOPY;

FERRIC COMPOUNDS; HELA CELLS; HUMANS; IRON; MAGNETITE NANOPARTICLES; SENSITIVITY AND SPECIFICITY; SPECTROPHOTOMETRY, ULTRAVIOLET;

EID: 84868158514     PISSN: 15554309     EISSN: 15554317     Source Type: Journal    
DOI: 10.1002/cmmi.1493     Document Type: Article

References (35)

1. Bulte JWM, Arbab AS, Douglas T, Frank JA. Preparation of magnetically labeled cells for cell tracking by magnetic resonance imaging. Meth Enzymol 2004; 386: 275-299.
2. Frank JA, Anderson SA, Kalish H, Jordan EK, Lewis BL, Yocum GT, Arbab AS. Methods for magnetically labeling stem and other cells for detection by in vivo magnetic resonance imaging. Cytotherapy 2004; 6: 621-625.
3. Arbab AS, Frank JA. Cellular MRI and its role in stem cell therapy. Regen Med 2008; 3: 199-215.
4. Arbab AS, Janic B, Pawelczyk E, Haller J, Liu W, Frank JA. In vivo cellular imaging for translational medical research. Curr Med Imag Rev 2009; 5: 19-38.
5. Liu W, Frank JA. Detection and quantification of magnetically labeled cells by cellular MRI. Eur J Radiol 2009; 70: 258-264.
6. Cromer Berman SM, Walczak P, Bulte JW. Tracking stem cells using magnetic nanoparticles. Wiley Interdiscip Rev Nanomed Nanobiotechnol 2011; 3: 343-355.
7. Laurent S, Boutry S, Mahieu I, Vander Elst L, Muller RN. Iron oxide based MR contrast agents: from chemistry to cell labeling. Curr Med Chem 2009; 16: 4712-4727.
8. Frank JA, Miller BR, Arbab AS, Zywicke HA, Jordan EK, Lewis BK, Bryant HL, Bulte JW. Clinically applicable labeling of mammalian and stem cells by combining superparamagnetic iron oxides and transfection agents. Radiology 2003; 228: 480-487.
9. Arbab AS, Yocum GT, Kalish H, Jordan EK, Anderson SA, Khakoo AY, Read EJ, Frank JA. Efficient magnetic cell labeling with protamine sulfate complexed to ferumoxides for cellular MRI. Blood 2004; 104: 1217-1223.
10. Sadek H, Latif S, Collins R, Garry MG, Garry DJ. Use of ferumoxides for stem cell labeling. Regen Med 2008; 3: 807-816.
11. Janic B, Rad AM, Jordan EK, Iskander ASM, Ali AM, Frank JA, Arbab AS. Optimization and validation of FePro cell labeling method. PLoS One 2009; 4: e5873.
12. Thu MS, Bryant LH, Coppola T, Jordan EK, Budde MD, Lewis BK, Chaudhry A, Ren J, Varma NR, Arbab AS, Frank JA. Self-assembling nanocomplexes by combining ferumoxytol, heparin and protamine for cell tracking by magnetic resonance imaging. Nat Med 2012; 3: 463-467.
13. Kim HS, Oh SY, Joo HJ, Son KR, Song IC, Moon WK. The effects of clinically used MRI contrast agents on the biological properties of human mesenchymal stem cells. NMR Biomed 2010; 23: 514-522.
14. van Buul GM, Farrell E, Kops N, van Tiel ST, Bos PK, Weinans H, Krestin, GP, van Osch, GJ, Bernsen MR. Ferumoxides-protamine sulfate is more effective than ferucarbotran for cell labeling: implications for clinically applicable cell tracking using MRI. Contrast Media Mol Imag 2009; 4: 230-236.
15. Wang L, Wang Z, Frank TG, Brown SI, Chudek, SA, Cuschieri A. Rapid and efficient cell labeling with a MRI contrast agent by electroporation in the presence of protamine sulfate. Nanomedicine-UK 2009; 4: 305-315.
16. Xie D, Qiu B, Walczak P, Li X, Ruiz-Cabello J, Minoshima S, Bulte JW, Yang X. Optimization of magnetosonoporation for stem cell labeling. NMR Biomed 2010; 23: 480-484.
17. Walczak P, Kedziorek DA, Gilad AA, Lin S, Bulte JW. Instant MR labeling of stem cells using magnetoelectroporation. Magn Reson Med 2005; 54: 769-774.
18. Bulte JW, Miller GF, Vymazal J, Brooks RA, Frank JA. Hepatic hemosiderosis in non-human primates: quantification of liver iron using different field strengths. Magn Reson Med 1997; 37: 530-536.
19. Boutry S, Forge D, Burtea C, Mahieu I, Murariu O, Laurent S, Vander Elst L, Muller RN. How to quantify iron in an aqueous or biological matrix: a technical note. Contrast Media Mol Imag 2009; 4: 299-304.
20. Chertok B, Cole AJ, David AE, Yang VC. Comparison of electron spin resonance spectroscopy and inductively-coupled plasma optical emission spectroscopy for biodistribution analysis of iron-oxide nanoparticles. Mol Pharmacol 2010; 7: 375-385.
21. Carneiro AAO, Vilela GR, de Araujo DB, Baffa O. In vivo tissue characterization using magnetic techniques. Braz J Phys 2005; 36: 9-15.
22. Rad AM, Janic B, Iskander ASM, Soltanian-Zadeh H, Arbab AS. Measurement of quantity of iron in magnetically labeled cells: comparison among different UV/VIS spectrometric methods. Biotechniques 2007; 43: 627-628.
23. Riemer J, Hoepken HH, Czerwinska H, Robinson SR, Dringen R. Colorimetric ferrozine-based assay for the quantitation of iron in cultured cells. Anal Biochem 2004; 331: 370-375.
24. Bohm I. Magnetic resonance cell-tracking studies: spectrophotometry-based method for the quantification of cellular iron content after loading with superparamagnetic iron oxide nanoparticles. Mol Imag 2011; 10: 270-277.
25. Oldenburg AL, Gallippi CM, Tsui F, Nichols TC, Beicker KN, Chhetri RK, Spivak D. Magnetic and contrast properties of labeled platelets for magnetomotive optical coherence tomography. Biophys J 2010; 99: 2374-2383.
26. Veiseh O, Gunn JW, Kievit FM, Sun C, Fang C, Lee J, Zhang M. Inhibition of tumor-cell invasion with chlorotoxin-bound superparamagnetic nanoparticles. Small 2009; 5: 256-264.
27. Danhier P, Preter GD, Bountry S, Mahieu I, Leveque P, Magat J, Haufroid V, Sonveaux P, Bouzin C, Feron O, Muller RN, Jordan BF, Gallez B. Electron paramagnetic resonance as a sensitive tool to assess the iron oxide content in cells for MRI cell labeling studies. Contrast Media Mol Imaging 2012; 7: 302-307.
28. Kowalczyk M, Banach M, Rysz J. Ferumoxytol: a new era of iron deficiency anemia treatment for patients with chronic kidney disease. J Nephrol 2011; 24: 717-722.
29. Hasan DM, Mahaney KB, Magnotta VA, Kung DK, Lawton MT, Hashimoto T, Winn HR, Saloner D, Martin A, Gahramanov S, Dósa E, Neuwelt E, Young WL. Macrophage imaging within human cerebral aneurysms wall using ferumoxytol-enhanced MRI: a pilot study. Arterioscler Thromb Vasc Biol 2012; 32: 1032-1038.
30. Hamilton BE, Nesbit GM, Dósa E, Gahramanov S, Rooney B, Nesbit EG, Raines J, Neuwelt EA. Comparative analysis of ferumoxytol and gadoteridol enhancement using T1- and T2-weighted MRI in neuroimaging. AJR Am J Roentgenol 2011; 197: 981-988.
31. Dósa E, Tuladhar S, Muldoon LL, Hamilton BE, Rooney WD, Neuwelt EA. MRI using ferumoxytol improves the visualization of central nervous system vascular malformations. Stroke 2011; 42: 1581-1588.
32. Neuwelt EA, Várallyay P, Bagó AG, Muldoon LL, Nesbit G, Nixon R. Imaging of iron oxide nanoparticles by MR and light microscopy in patients with malignant brain tumours. Neuropathol Appl Neurobiol 2004; 30: 456-471.
33. Castaneda RT, Khurana A, Khan R, Daldrup-Link HE. Labeling stem cells with ferumoxytol, an FDA-approved iron oxide nanoparticle. J Vis Exp 2011; 57: e3482. DOI: 10.3791/3482.
34. Rossman GR, Thibeault J, Gray HB. Simultaneous pair electronic excitations in a binuclear iron(III) complex. Chem Phys Lett 1970; 6: 26-28.
35. Amendola V, Meneghetti M. Size evaluation of gold nanoparticles by UV-vis spectroscopy. J Phys Chem C 2009; 113: 4277-4285.